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INTRODUCTION
Myelin, the lipid-rich insulation that ensures rapid nerve 
conduction velocity, is generated by specialized glial cells: 
oligodendrocytes in the central nervous system (CNS) 
and Schwann cells (SCs) in the peripheral nervous system 
(PNS; Nave and Trapp, 2008). Disruption of the myelin 
sheath in patients with peripheral neuropathies (e.g., Char-
cot-Marie-Tooth disease [CMT]) causes severe symptoms, 
including pain and neuronal damage that can ultimately lead 
to paralysis (Harel and Lupski, 2014). Proper myelination is 
required for a high quality of life in humans, yet the molecu-
lar mechanisms governing myelinating glial cell development 
and myelination are poorly understood.
Recent works from our laboratory and others have 
identified the adhesion class of G protein-coupled recep-
tors (aGPCRs) as key regulators of myelinating glial cell 
development (Monk et al., 2009, 2011; Glenn and Talbot, 
2013; Mogha et al., 2013; Shin et al., 2013a; Liebscher et al., 
2014; Ackerman et al., 2015; Giera et al., 2015; Petersen et 
al., 2015; Küffer et al., 2016; Salzman et al., 2016). aGPCRs 
represent the second-largest class of GPCRs in humans, yet 
remain largely understudied because of their genomic and 
structural complexity (Hamann et al., 2015). In brief, ma-
ture aGPCRs exist at the cell membrane as bipartite receptors 
consisting of an N-terminal fragment (NTF) facilitating ad-
hesion and a C-terminal fragment (CTF) containing the sev-
en-transmembrane pass signaling domain, and modulation of 
NTF–CTF interactions is associated with receptor activation 
(Hamann et al., 2015). Using a transcription activator-like 
effector nuclease–induced mutant allele of the aGPCR 
Gpr56/Adgrg1 in zebrafish (gpr56stl13/stl13), we previously 
determined that Gpr56 regulates proliferation of oligoden-
drocyte precursor cells (Ackerman et al., 2015). Analysis of 
published expression datasets revealed that Gpr56 is also ro-
bustly expressed in SCs (Miller et al., 2006; Weiss et al., 2016). 
Given the importance of Gpr126 (a closely related aGPCR) 
in regulating SC biology (Monk et al., 2009, 2011; Glenn 
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and Talbot, 2013; Mogha et al., 2013; Liebscher et al., 2014; 
Petersen et al., 2015; Küffer et al., 2016) and the established 
role of GPR56 in oligodendrocyte precursor cells (Acker-
man et al., 2015; Giera et al., 2015; Salzman et al., 2016), we 
sought to determine if GPR56 also regulates myelinating glial 
development in the PNS.
Here, we use zebrafish and rodent models to define the 
role of Gpr56 in SC development and myelination. Whereas 
loss of Gpr56 from the CNS results in hypomyelination be-
cause of a reduction in oligodendrocyte precursor cell pro-
liferation and mature oligodendrocyte numbers, we find no 
apparent defect in SC proliferation or overall SC number in 
Gpr56 mutants. Instead, we demonstrate that GPR56 func-
tions through RhoA in early SC development to regulate 
proper radial sorting of axons by SCs and that disrupted radial 
sorting in Gpr56 mutants likely results from altered cytoskel-
etal remodeling. Additionally, we find that loss of Gpr56 from 
mature nerve results in multiple myelin structural abnormal-
ities, including increased myelin thickness, aberrant myelin 
domain organization, shortened internode length, and failed 
myelin maintenance. Finally, we identify plectin as a novel 
interacting partner of GPR56 in SCs. Plectin is a large cyto-
skeletal linker protein that causes multiple diseases (plectinop-
athies) when mutated in humans (Winter and Wiche, 2013). 
The most common plectinopathy is epidermolysis bullosa 
simplex with muscular dystrophy, a rare skin-blistering dis-
order that presents with late-onset muscular dystrophy, but 
mutations in PLE CTIN have also been linked to defects in 
peripheral myelin ultrastructure (Bauer et al., 2001). We find 
that plectin physically interacts with GPR56, that plectin lev-
els are up-regulated in the absence of Gpr56 (as expected for a 
receptor-ligand pair), and that Plectin mutant SCs phenocopy 
Gpr56 mutant SCs, suggesting that these proteins function 
together to regulate SC biology. Together, our studies define 
GPR56 as a novel and evolutionarily conserved regulator of 
peripheral nerve development and function with important 
implications for human health and disease.
RESULTS
GPR56 regulates SC radial sorting via 
Gα12/13 and RhoA signaling
Radial sorting is the process by which immature SCs en-
compass bundles of naked axons and sort individual axonal 
segments into a 1:1 SC/axon segment relationship. The tim-
ing of radial sorting is essential; when radial sorting is im-
paired, both myelination and peripheral nerve maturation are 
delayed (Jessen and Mirsky, 2005; Feltri et al., 2016). Anal-
ysis of peripheral nerves from Gpr56 mouse mutants (Li et 
al., 2008) revealed radial sorting delays by transmission EM 
(TEM; Fig. 1). At postnatal day (P) 3 in Gpr56 mouse mu-
tant sciatic nerves (SNs; n = 4 mutant mice), the number of 
axons sorted 1:1 with SCs was significantly reduced relative 
to WT (n = 3) and heterozygous (n = 3) siblings (Fig. 1 G; 
P < 0.0002, one-way ANO VA). Additionally, we observed 
abnormal cytoplasmic protrusions from sorting SCs (indic-
ative of disrupted cytoskeletal rearrangements, Fig. 1, I and 
J), basal lamina trails reflecting aberrant SC process extension 
and retraction during radial sorting (Fig.  1  K), along with 
other myelin abnormalities in the SNs of Gpr56 mutant mice 
(Fig.  1, L–N; P < 0.002, one-way ANO VA). Deficient SC 
precursor proliferation can cause radial sorting delays (Feltri 
et al., 2016), and GPR56 is a known regulator of cell division 
(Wu et al., 2013; Bae et al., 2014; Ackerman et al., 2015; Giera 
et al., 2015); thus, we first tested if Gpr56 mutant SCs were 
less proliferative than WT. Interestingly, SC proliferation and 
total number were unaffected in Gpr56 mouse mutant SNs, as 
was overall peripheral (saphenous) nerve size (Fig. S1). There-
fore, in contrast to its role in oligodendrocyte precursor cells, 
Gpr56 is dispensable for SC proliferation.
These findings suggest that GPR56 does not regulate 
radial sorting by affecting SC numbers. Given the cytoplasmic 
defects observed on P3 (Fig. 1, I and J), we hypothesized that 
GPR56 may function in controlling dynamics of immature 
SC protrusions and/or adhesion to axonal membranes. To test 
this, we used a modified Boyden chamber to mimic axon–SC 
interactions during radial sorting (Poitelon et al., 2015). In 
brief, purified rat SCs were seeded within the upper com-
partment of a Boyden chamber in which neuronal fragments 
were suspended below to induce SC “pseudopod” (mimick-
ing cytoplasmic protrusion) growth. Pseudopods were then 
collected, processed, and analyzed by long-gradient nano 
reversed-phase liquid chromatography–mass spectrometry 
(LC-MS; Fig. 2, A and B; see Materials and methods for full 
details). Indeed, we determined that GPR56 is highly en-
riched in SC pseudopods (Fig. 2 C and Dataset 1), supporting 
the hypothesis that GPR56 autonomously regulates SC cyto-
plasmic protrusion dynamics during radial sorting.
In the nervous system, GPR56 primarily signals through 
Gα12/13 and RhoA (Iguchi et al., 2008; Luo et al., 2011; Ack-
erman et al., 2015; Giera et al., 2015), and indeed, Gα13 (pro-
tein symbol GNA13) and RhoA signaling proteins are also 
enriched in SC pseudopods (Fig.  2, C and D; and Dataset 
1). Further, we found a significant reduction in the relative 
concentration of active, GTP-bound RhoA in Gpr56 mutant 
nerves relative to WT sibling nerves on P6. We also detected 
a significant decrease in active, GTP-bound RhoA in het-
erozygous nerves relative to WT (Fig.  2  E, n = 12 nerves 
per genotype across three replicates), consistent with the ob-
servation that Gpr56+/− animals exhibit some mutant phe-
notypes onP3 (Fig. 1 H; P < 0.039, one-way ANO VA). To 
test whether GPR56 functions through Gα12/13 and RhoA to 
promote radial sorting, we used standard genetic manipula-
tions to either enhance (via inhibition of Gα12/13) or suppress 
(via transient overexpression of constitutively active RhoA) 
radial sorting defects in gpr56stl13/stl13 mutant zebrafish (Lin et 
al., 2009; Ackerman et al., 2015). Strikingly, injection of anti-
sense morpholinos that block translation of the three zebra- 
fish transcripts encoding Gα12/13 (3MO) strongly enhanced 
radial sorting defects in the posterior lateral line nerve (pLLn) 
of gpr56stl13/stl13 mutants and induced radial sorting defects in 
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heterozygote and WT siblings in a dose-dependent manner (P 
< 0.001, two-way ANO VA; Fig. 3, A–I and M). Conversely, 
transient overexpression of synthetic mRNA encoding con-
stitutively active RhoA (rhov14) completely suppressed radial 
sorting defects in gpr56stl13/stl13 mutants, suggesting a positive 
role for RhoA in radial sorting via Gpr56 signaling (control 
WT vs. control gpr56stl13/stl13: P < 0.023, unpaired Student’s 
t test; rhov14 injected WT vs. rhov14 injected gpr56stl13/stl13: 
P < 0.58, unpaired Student’s t test; Phenol red: n = 3; WT: 
n = 3 stl13+/−, n = 4 stl13−/−; +rhov14: n = 3 animals per 
genotype; Fig. 3, J–L, O, and P). Total axon number was not 
affected by experimental conditions throughout (Fig.  3, N 
and Q–R). The importance of RhoA in maintenance of 
cell–cell contact points has been established (Parsons et al., 
2010), suggesting that sorting delays in Gpr56 mutants may 
not result from impaired process extension but rather from an 
inability of SCs to maintain secure contacts with target axons 
during radial sorting. This hypothesis is consistent with the 
aforementioned signs of SC process retraction observed in P3 
mouse mutant SNs (Fig. 1 K).
Myelin domain organization is impaired in Gpr56 mutants
We’ve defined that GPR56 signaling through RhoA is re-
quired for timely radial sorting of axons during peripheral 
nerve development. Although this phenotype did not persist 
through adulthood (Fig.  4, A–D; n = 3 animals per geno-
type, P < 0.57, unpaired Student’s t test; Fig. S2, A–D), we 
noted several other pronounced alterations in mature periph-
Figure 1. GPR56 is required for efficient radial sorting. (A–F) TEM images of SN from (A and B) WT (n = 3), (C and D) Gpr56+/− (n = 3), and (E and F) 
Gpr56−/− mice (n = 4) on P3. SC precursor nuclei (N) surrounding and within axon bundles in Gpr56−/− nerves. Higher magnification images: B, D, and F. Bars, 
2 µm. (G) Quantification of axons sorted 1:1 with SCs (***, P < 0.0002, one-way ANO VA). (H) Quantification of the number of axons per unsorted bundle 
(*, P < 0.04, one-way ANO VA). (I–M) TEM images of P3 SN Gpr56−/− (n = 4) animals. Bars: (I, J, L, and M) 1 µm; (I inset and K) 500 nm. (I) Large bundles 
of unsorted axons surrounded by SC processes are observed in a Gpr56−/− SN. Some SCs also exhibited abnormal cytoplasmic protrusions (arrowhead). 
Higher magnification of the boxed in region shown within the inset. In addition, (J, L, and M) myelin abnormalities (outfoldings) and (K) nearly naked axons 
associated with SCs and partially surrounded by SC basal lamina (arrows) were often observed. (N) Quantification of the percent of axons with myelin 
abnormalities revealed a significant increase in myelin defects in Gpr56−/− nerves compared with WT controls (**, P < 0.002, one-way ANO VA). (G, H, and 
N) Error bars represent SEM. 
 o
n
 M
arch 13, 2018
jem.rupress.org
D
ow
nloaded from
 
GPR56/ADG RG1 in peripheral nerve | Ackerman et al.944
eral nerve. First, we observed Remak bundle defects. Remak 
bundles are groups of small caliber axons sorted and individ-
ually encompassed by a single nonmyelinating SC. In Gpr56 
mutants, Remak bundle morphology was impaired, such that 
interdigitation of SC processes between axons within a sin-
gle bundle was incomplete (Fig.  4  E, P < 0.027, one-way 
ANO VA). In addition, we noted several deviations in mature 
myelin ultrastructure. Myelin thickness was significantly in-
creased in Gpr56 mouse mutant SNs (Fig. 4 F; reflected in 
lower mean G-ratio, ∼180 fibers analyzed from three ani-
mals per genotype, P < 0.002, one-way ANO VA), and we 
noted myelin outfoldings commonly associated with hyper-
myelination (Fig. 4 B).
In the PNS, myelin internodes possess two primary 
structural domains: Cajal bands (longitudinal channels of SC 
cytoplasm) and appositions (where the outermost layer of my-
elin contacts the SC plasma membrane; Sherman and Brophy, 
2005). Strikingly, we also observed defects in the suborgani-
zation of peripheral myelin into Cajal bands and appositions 
in Gpr56 mouse mutant SCs (Fig.  4  G; 154 WT and 168 
Gpr56−/− fibers from three animals per genotype, P < 0.002, 
one-way ANO VA), as well as SC cytoplasmic abnormalities 
in gpr56stl13/stl13 zebrafish mutant SCs (Fig. S2 B). The func-
tion of Cajal bands is poorly understood because few proteins 
have been linked to Cajal band formation (Court et al., 2004, 
2009; Sherman et al., 2012; Walko et al., 2013). Of these pro-
teins, Periaxin has been best studied; Periaxin stabilizes SC 
appositions, and Periaxin mutations cause neuropathy-like 
phenotypes in mouse and CMT disease in humans (Guilbot 
et al., 2001). Although Periaxin is well characterized for its 
role in CMT, mutations in PLE CTIN (a cytolinker protein 
shown to regulate SC domain organization) are similarly as-
Figure 2. GPR56 and interacting proteins are 
enriched in pseudopods after induction by mem-
branes of DRG neurons dependent on BDNF and 
NT-3. (A) Schematic representation of the pseu-
dopod assay. DRG were dissected from E15.5 rats. 
Neurons were selected with BDNF and NT-3 growth 
factors. After purification, neurons were collected and 
homogenized. SCs were induced or not with neuronal 
membrane suspension. Pseudopods (Ps) were isolated 
from cell bodies (CBs), and both were analyzed by MS. 
(B) Quantification by bicinchoninic acid assay of the 
protein content of SC pseudopods and CBs after in-
duction. Data are shown as mean ± SD; n (indepen-
dent experiment) = 3. *, P < 0.05. (C) Distribution of 
proteins enriched by neuronal membranes. The ab-
scissa axis indicates relative polarization of a protein 
between P and CB. The ordinate axis indicates rela-
tive enrichment of a protein by neuronal membranes 
in comparison to noninduced condition. Both GPR56 
and GNA13 are found enriched in SC Ps after neuronal 
membranes induction. (D) Protein ontology analysis 
of the pathways most enriched in SC Ps. RhoA sig-
naling is enriched by neuronal membranes. For more 
complete listings, see Dataset 1. Student’s t test (un-
paired) was used to test for statistical significance. 
(E) GTP-RhoA pull-down assay revealed a significant 
decrease in the proportion of GTP-RhoA (active) to 
total RhoA in Gpr56−/− and Gpr56+/− animals rela-
tive to WT controls on P6 (**, P < 0.01, unpaired Stu-
dent’s t test; data are shown as mean ± SEM; n = 4 
nerves from n = 2 animals per technical replicate; n = 
3 technical replicates).
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Figure 3. Gpr56 signals through Gα12/13 
and RhoA to promote radial sorting. (A–I) 
TEM images of the pLLn of WT, gpr56stl13/+, and 
gpr56stl13/stl13 larvae injected with (A–C) phenol 
red control (n = 6 animals per genotype), (D–F) 
0.5 ng 3MOs targeting Gα12/13 signaling (3MO = 
gna12-MO, gna13a-MO, and gna13b-MO; n = 
6 WT, n = 5 gpr56stl13/+, and n = 5 gpr56stl13/stl13 
animals examined), or (G–I) 1 ng 3MO (n = 
3 animals per genotype). (J–L) In a separate 
series of experiments, animals were injected 
with constitutively active rhov14 (rhov14: n = 
3 animals per genotype; control: n = 3 each 
WT and gpr56stl13/+, n = 4 gpr56stl13/stl3). Sorted 
axons are pseudocolored orange. Myelinated 
axons are pseudocolored blue. (A–L) Bar, 1 
µm. (M) Two-way ANO VA analysis revealed 
a significant interaction between genotype 
and treatment for 3MO experiments (****, P < 
0.0001). Tukey’s multiple comparisons test was 
also performed and found a significant reduc-
tion in the number of sorted axons between 
control WT embryos and control heterozygous 
(****, P < 0.0001) as well as control mutant 
embryos (****, P < 0.0001). A significant de-
crease in sorted axon number was observed 
between 0.5-ng 3MO-treated WT and -treated 
heterozygous (***, P < 0.001) and -treated 
mutant embryos (****, P < 0.0001). No signif-
icant comparisons were found in the 1-ng 
3MO condition. (N) Total axon number is un-
affected by genotype or treatment (two-way 
ANO VA). (O) Quantification of the number 
of axons sorted 1:1 in phenol red controls (P 
< 0.03, unpaired Student’s t test) compared 
with (P) rhov14-injected embryos (no sig-
nificant differences). (Q and R) Total axon 
number was unchanged by test condition 
(unpaired Student’s t test). Data reflect two 
independent experimental replicates. (M–R) 
Error bars represent SEM.
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Figure 4. GPR56 regulates mature myelin ultrastructure and domain organization. (A and B) TEM images of WT (n = 3) and Gpr56 mutant mouse (n 
= 3) SNs on P21. Bar, 2 µm. White arrow denotes myelin outfolding. Black arrowheads denote morphologically WT Remak bundles, which are incompletely 
formed in Gpr56 mutants (B, white arrowhead/inset). The asterisk marks an axon with no appositions. (C–E) Quantification of (C) total number of myelin-
ated axons (P < 0.45, one-way ANO VA), (D) overall axon number (P < 0.81, one-way ANO VA), and (E) percentage of bundles containing axons that are not 
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sociated with myelin maintenance defects in mice and neu-
ropathy-like symptoms in humans (Walko et al., 2013; Winter 
and Wiche, 2013), demonstrating the importance of myelin 
domain architecture for sustained PNS health in humans. In-
terestingly, analysis by immunohistochemistry (IHC) revealed 
that in mature SNs, GPR56 is specifically localized to discrete 
cytoplasmic domains on the abaxonal SC membrane (Fig. 4, 
I–K) and, thus, poised to regulate Cajal band formation.
Altered expression of cytoskeletal genes in developing and 
mature Gpr56 mutant nerves
GPR56 signals via RhoA to regulate radial sorting (Figs. 1, 
2, and 3), but the downstream signaling pathway(s) through 
which GPR56 regulates the development of mature myelin 
are not known. To determine what signaling pathway(s) may 
underlie the phenotypes observed in Gpr56 mutants during 
SC maturation in contrast to early SC development (radial 
sorting), we performed RNA sequencing (RNA-seq) on 
RNA isolated from SNs of P21 and P3 mutants and WT con-
trols, respectively (n = 3 per genotype on P21; n = 4 per gen-
otype on P3; Fig. S3). Importantly, we observed a significant 
decrease in the expression of Gpr56 at both developmental 
time points (Fig. S3 F). In accordance with the hypothesis 
that GPR56 normally functions in SC pseudopods to pro-
mote stable cell-cell contacts during radial sorting, and with 
the abnormal SC cytoplasmic extensions observed in Gpr56 
mutant SCs on P3 (Fig. 1, I and J), we observed a significant 
increase in the expression of genes associated with dynamic 
actin filaments in mutant SN harvested on P3 during active 
radial sorting (Fig. S3 D). We also found a statistically sig-
nificant enrichment (−log[p-value] <20) in gene ontology 
(GO) processes associated with actin dynamics, including (a) 
actin-myosin filament sliding, (b) actin-mediated cell con-
traction, (c) actin filament–based movement, and (d) actin 
filament–based process using g:Profiler (Dataset 2).
Interestingly, we also observed significant changes in ex-
pression of genes related to the cytoskeleton on P21, when 
Cajal band defects are pronounced in Gpr56 mutant nerves. 
Although we detected no differential expression of genes re-
lating to the actin cytoskeleton, the expression of genes that 
promote microtubule assembly (Map2 and Ttll7) was signifi-
cantly increased in mutant nerves relative to controls, whereas 
expression of genes that promote microtubule disassembly 
(e.g., Eml2) was significantly down-regulated (Fig. S3 E). We 
also found a statistically significant enrichment (-log[p-value] 
< 4) in the Cytoskeletal Remodeling GO pathway by g:Pro-
filer (Dataset 2). The molecular mechanisms that guide Cajal 
band formation are poorly understood; however, microtubule 
disorganization is a common feature of other mutants that 
lack Cajal bands (Court et al., 2004). These findings suggest 
that precise microtubule organization is necessary for Cajal 
band formation and represents an important area of future re-
search into the development of these understudied domains.
In addition to changes in the expression of genes involved 
in microtubule dynamics, we also observed a striking dysreg-
ulation of a cluster of genes that share the SRE BP-1 binding 
motif. Although we observed a modest increase in expression 
of SRE BP1 target genes on P3, by P21 we noted a signifi-
cant decrease in the expression of genes that share the SRE 
BP-1 motif. Loss of sterol regulatory element-binding factor- 
1c (Srebf1c) results in increased peripheral myelin thick-
ness, Remak bundle defects, and peripheral neuropathy-like 
symptoms in mice (Cermenati et al., 2015). Finally, although 
the authors did not formally examine the role of Srebf1c in 
Cajal band formation, Srebf1c mutants did not present with 
overt Cajal band defects based on published TEM images of 
Srebf1c−/− peripheral nerve (Cermenati et al., 2015).
Our transcriptional profiling experiments (Fig. S3 and 
Dataset 2), combined with our genetic and biochemical 
analyses (Figs. 2 and 3) demonstrate that GPR56 signaling 
through Gα12/13 and RhoA is required to modify the actin 
skeleton for proper radial sorting during early SC develop-
ment. These data further suggest that, during SC maturation, 
Gpr56 signals through SRE BP1 pathway to regulate lipid 
biogenesis and Remak bundle biology and through an al-
ternative mechanism to modify microtubule dynamics for 
proper Cajal band assembly.
Gpr56 is required for SC myelin maintenance
Defective organization of the myelin sheath precedes neurop-
athy-like symptoms in all mutants (e.g., Periaxin, Drp2, and 
Plectin) previously shown to have Cajal band defects (Court et 
al., 2004; Sherman et al., 2012; Walko et al., 2013). Gpr56 mu-
tant mice present with Cajal band/apposition phenotypes, as 
well as Srebf1c-like hypermyelination and Remak SC defects 
(Cermenati et al., 2015); thus, we hypothesized that Gpr56 
mutants would develop neuropathy-like symptoms with age 
as is observed in both Cajal band and Srebf1c mutants. Ul-
trastructural analyses of mouse SNs on P90, P180, and P300 
(Fig. 5, A–I) revealed small yet significant increases in the per-
cent of axons with abnormal myelin profiles in Gpr56 mu-
tants and heterozygotes relative to WT siblings at each stage 
(n = 3 animals minimum per genotype/time point). Myelin 
abnormalities were composed of outfoldings and other de-
fects: axon regeneration signatures (bands of Büngner), SCs 
myelinating other myelinating and Remak SCs, extensive 
fully sheathed in Gpr56 mutants and WT sibling nerves (*, P < 0.03, one-way ANO VA). Error bars represent SEM. (F) Plots of G-ratios in mutants and WT 
controls (P < 0.002, one-way ANO VA). (G) TEM images of Gpr56−/− myelinated axons with 0, 1, 2, or 3 appositions. (H) Distribution of the percentage of 
myelinated axons (mean ± SD) per apposition number in WT (white bars) and Gpr56−/− SNs (black bars, **, P < 0.002, one-way ANO VA). (I–K) IHC showing 
GPR56 (green), DAPI (nuclear stain, blue), and MBP (marker of mature myelin) localization on P21 SNs. In WT SNs, GPR56 is detected in pockets (arrowheads) 
outside of MBP-positive rings but absent from mature axons. (J) GPR56 stain alone. (K) MBP stain alone. Bar, 5 µm.
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cytoplasmic extensions, minifascicle formation, myelin de-
bris (Fig.  5, J–O), and disrupted Schmidt-Lanterman inci-
sures (Fig. S4, A and B). In addition, we observed a significant 
interaction between genotype and age with respect to my-
elin abnormalities (P < 0.0001, two-way ANO VA; Fig. 5 P), 
indicating that these phenotypes worsen with time. Axon 
number remained largely unchanged with age, suggesting 
that loss of Gpr56 does not induce widespread neuronal loss 
(Fig.  5, Q–S). Analysis of Gpr56 mouse mutant dorsal and 
ventral spinal roots, composed of purely sensory and purely 
motor neurons, respectively, revealed similar demyelinating 
signatures (Fig. S4, C–L).
Given the importance of Gpr56 in the formation of 
Cajal bands, structures that span the entire internode and 
can reach nearly 1 mm in length in adult mice (Court et al., 
2004), we hypothesized that standard TEM analysis may un-
derestimate myelin abnormalities in Gpr56 mutants. Indeed, 
analysis of serial EM reconstructions of Gpr56 mouse mutant 
SN on P90 revealed a cumulative average of 68 ± 10% axons 
showing at least one myelin defect over 15 µm of internode, 
compared with 15 ± 6% in WT controls (Fig. 6, Fig. S5, and 
Videos 1, 2, 3, and 4).
Gpr56 mutants display neuropathy-like symptoms with age
In addition to myelin loss, impaired Cajal band formation 
in Periaxin mutants is associated with shortened internodes, 
leading us to hypothesize that loss of Gpr56 would affect 
internode length (Court et al., 2004). Teased nerve fiber 
analysis revealed a significant reduction in internode length 
on P6 (not depicted) and on P21 in Gpr56 mutant mice 
(Fig.  7, A–C; P < 0.05, one-way ANO VA). Moreover, on 
P180, Gpr56 mutants displayed a hindlimb clasping pheno-
type (Fig. 7, D and E), and both Gpr56+/− (n = 16 on P180, 
n = 15 on P300) and Gpr56−/− mutants (n = 13 on P180, 
n = 12 on P300) performed poorly relative to WT controls 
(n = 11 on P180, n = 10 on P300) on the accelerated ro-
tarod, indicative of impaired sensory-motor coordination 
and reduced grip strength (Fig. 7 F, P < 0.001; Fig. 7 G, P 
< 0.005; two-way ANO VA analysis). To test whether behav-
ioral deficits observed in Gpr56 mutant and heterozygous 
mice reflected a reduction in nerve function, we performed 
electromyography (EMG) analyses in vivo and found a sig-
nificant increase in EMG latency in Gpr56 mutants (n = 
11) relative to controls (n = 5 WT, n = 12 Gpr56+/−) in 
animals aged P200–P300 (Fig.  7  H; P < 0.001, one-way 
ANO VA) with a corresponding reduction in response ve-
locity (Fig. 7 I; P < 0.001, one-way ANO VA). See Fig. 7 J 
for example traces. Interestingly, although we observed no 
overt changes in Na+ channel structure by teased nerve anal-
ysis (Fig. 7, A and B), we detected a significant increase in 
the expression of genes related to K+ channel activity on 
P21 and a significant decrease in the expression of the Na+ 
channel clustering protein Ndrg4 (Fontenas et al., 2016) on 
both P3 and P21 (Fig. S3, C and D). GPR56 is also localized 
to sensory neurons (Fig. S4, M–O), and future work with 
cell type–specific knockout lines will be important for un-
derstanding the relative contributions of GPR56 in neurons 
versus SCs to peripheral nerve function.
Plectin is a novel interacting partner of 
Gpr56 in peripheral nerve
To further define how GPR56 regulates SC function, we 
next sought to determine which protein(s) interact with 
GPR56 to facilitate peripheral nerve development. We re-
cently showed that cellular prion protein (Prnp/PrpC) is se-
creted from neurons and modulates GPR126 (an aGPCR 
closely related to GPR56) signaling and SC function. We 
used the previously published N-terminal flexible tail ([FT] 
residues 23–120) of PrPC (Küffer et al., 2016), which can ac-
tivate GPR126 signaling in vitro and in vivo, to test whether 
PrPC can also activate Gpr56 signaling in vitro. We did not 
observe any significant increase in GPR56 signaling either 
through RhoA or through an SRE-mediated transcriptional 
response to FT compared with application of collagen III, 
a known ligand of GPR56 (Luo et al., 2011; Fig. 8, A and 
B; P < 0.03, unpaired Student’s t test). FT activates Gpr126 
signaling through cAMP; to test whether GPR56 may signal 
through this alternative pathway in response to FT, we mea-
sured cAMP levels after FT addition to GPR126 or GPR56. 
As previously shown, FT robustly stimulates cAMP signaling 
through GPR126 (Küffer et al., 2016) but had no effect on 
GPR56 (Fig. 8 C; P < 0.0027, unpaired Student’s t test).
We next used an unbiased mass-spectrometry screen to 
determine what protein(s) physically interact with GPR56 
(unpublished data). Interestingly, the top hit from this screen 
was plectin, a large cytolinker protein known to interact 
with and modulate cell surface signaling molecules through 
its coordinate reorganization of the actin and intermediate 
filament cytoskeletal networks (Winter and Wiche, 2013). 
PLE CTIN is also mutated in a series of human diseases 
termed plectinopathies, including epidermolysis bullosa 
simplex with muscular dystrophy, a skin blistering disorder 
that also presents with neuropathy-like symptoms because 
of degeneration of intramuscular myelinated nerves (Bauer 
et al., 2001; Winter and Wiche, 2013). First, we verified that 
GPR56 and plectin physically interact in WT P5 SNs (n = 8 
nerves from four animals) by coimmunoprecipitation (co-IP; 
Fig.  8  D). Interestingly, although we were able to detect 
binding of plectin to the CTF of GPR56 (not depicted), we 
observed robust binding of plectin to the extracellular NTF 
of GPR56 as well. Although this result most likely reflects 
binding of plectin to the larger GPR56 NTF-CTF complex, 
plectin has been shown to be secreted to the extracellular 
matrix in pathological contexts (Shin et al., 2013b). Future 
work will therefore be required to test whether plectin is 
secreted to serve as a direct activating ligand for GPR56.
We next tested whether loss of Gpr56 affects plectin 
expression in P6 SNs and found a significant increase in 
plectin levels in Gpr56 mutants (n = 7 replicates: 1 biolog-
ical replicate = 2 pooled nerves from one animal) relative 
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Figure 5. Gpr56 mutant mice show progressive accumula-
tion of myelin abnormalities. (A–C) TEM images of SNs from 
(A) WT (n = 3), (B) Gpr56+/− (n = 3), and (C) Gpr56−/− (n = 4) mice 
on P90. (D–F) TEM images of SNs from (D) WT, (E) Gpr56+/−, and 
(F) Gpr56−/− mice on P180 (n = 3 animals per genotype). (G–I) TEM 
images of SNs from (G) WT, (H) Gpr56+/−, and (I) Gpr56−/− mice 
on P300 (n = 3 animals per genotype). Red arrowheads denote 
abnormal myelin profiles. Black arrows mark Schmidt-Lanterman 
incisures. Black box highlights myelin debris observed by P300. 
(A–I) Bar, 2 µm. (J–O) SC defects and pathologies observed in 
Gpr56 heterozygous and mutant peripheral nerves included bands 
of Büngner (J; bar, 500 nm), aberrant myelination of other SCs (K; 
bar, 2 µm), abnormal cytoplasmic protrusions (L; bar, 500 nm), 
myelinated Remak bundles (M; bar, 4 µm), minifascicles (N; bar, 2 
µm), and myelin debris accumulation (O; bar, 2 µm). (P) Two-way 
ANO VA analysis revealed a significant interaction between age 
and genotype (****, P < 0.0001). Dunnett's multiple comparisons 
test also showed significant increases in the percent of axons 
with abnormal myelin profiles in Gpr56+/− and Gpr56−/− animals 
compared with WT at each time point (****, P < 0.0001). (Q–S) No 
significant differences between total myelinated axon number in 
WT and Gpr56−/− (P90: P < 0.15; P180: P < 0.44; P300: P < 0.89), 
nor between Gpr56+/− and Gpr56−/− (P90: P < 0.14; P180: P < 
0.13; P300: P < 0.52) at any stage. Unpaired Student’s t test. (P–S) 
Error bars represent SEM.
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to WT (n = 8 replicates) and heterozygous (n = 5 repli-
cates) siblings, as expected for a positive interacting partner 
of GPR56 (Fig. 8 E; P < 0.001, unpaired Student’s t test). 
Finally, plectin is strongly expressed in SCs and specifically 
localized to Cajal bands, and SC-specific KO of Plectin dis-
rupts myelin domain organization and causes neuropathy-like 
symptoms with age (Walko et al., 2013). Thus, plectin is a 
novel binding partner for GPR56, and the presence of phe-
nocopy coupled with both physical and genetic interactions 
(Fig. 8, D and E) strongly suggest that GPR56 and plectin 
function together to promote SC function and long-term 
health of peripheral nerves.
DISCUSSION
GPR56 in myelinating glial cell development
In the CNS, oligodendrocytes form the myelin sheath that 
both protects and insulates axons for rapid action potential 
propagation (Jessen and Mirsky, 2005). We previously defined 
GPR56 as a novel regulator of oligodendrocyte development 
(Ackerman et al., 2015; Giera et al., 2015; Salzman et al., 2016). 
In the CNS, GPR56 regulates the timing of the transition 
between oligodendrocyte precursor cell proliferation and dif-
ferentiation. In the absence of GPR56, oligodendrocyte pre-
cursor cells prematurely exit the cell cycle resulting in fewer 
numbers of myelinating oligodendrocytes; however, the my-
elinating oligodendrocytes that are produced generate pheno-
typically normal myelin (Ackerman et al., 2015; Giera et al., 
2015). In the PNS, SCs ensure long-term health of periph-
eral axons (Jessen and Mirsky, 2005). In contrast to the role 
of GPR56 in regulating the numbers of myelinating glia in 
the CNS, GPR56 does not affect SC proliferation or overall 
numbers. Instead, we observe novel and distinct functions of 
GPR56 in SC development (radial sorting) and in SC myelin-
ation (thickness, organization, and maintenance), and our data 
suggest defects in cytoskeletal dynamics as underlying causes 
of both early and late functions of GPR56 in peripheral nerve.
Figure 6. Gpr56 is required for myelin stability. (A–D) Serial scanning EM images (350, 100 nm apart) of WT and Gpr56−/− mouse SN on P90 (n = 3 
animals per genotype) were acquired and reconstructed to generate the WT and Gpr56−/− models shown in A and C, respectively. Single sections taken from 
multiple locations along the nerve (1–4) are shown below each model (dashed lines show approximate locations). The percentage of axons with abnormal 
myelin profiles was calculated per section over a 15-µm distance for the WT (B) and Gpr56 mutant (D) reconstruction and is graphed to show the percentage 
of abnormalities per section (green line), the average percentage of abnormalities over all sections (black line) and the cumulative percentage of abnormal-
ities (percentage of axons that show at least one abnormality over 15 µm [blue line]).
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RhoA-dependent regulation of radial sorting by GPR56
During early SC development, we find that GPR56 signaling 
is required for timely sorting of axons. Many proteins have 
been shown to function during radial sorting, including small 
Rho-GTPases (Nodari et al., 2007; Pereira et al., 2009; Feltri 
et al., 2016). RhoA is robustly expressed during radial sorting 
(Taylor et al., 2003; Melendez-Vasquez et al., 2004; Nodari 
et al., 2007) and specifically enriched in SC pseudopods. The 
function of RhoA in SCs has not been thoroughly examined, 
however, given the established role of the related Rho GTPase 
Rac in radial sorting (Nodari et al., 2007; Pereira et al., 2009; 
Feltri et al., 2016). Rac positively regulates the formation/
protrusion of lamellipodia-like structures from SCs, whereas 
RhoA activation typically inhibits process extension (Pereira 
et al., 2009). Indeed, up-regulation of Rho kinase (ROCK; 
a major downstream effector of RhoA signaling) in ILK 
SC-specific KO mice results in severe radial sorting delays 
because of impaired process extension (Pereira et al., 2009). 
In contrast, we find that reduced RhoA signaling in Gpr56 
mutants likewise impairs radial sorting, which can be restored 
upon transient overexpression of constitutively active RhoA.
These results indicate that RhoA levels must be very 
tightly regulated during SC development, because both in-
creased signaling in ILK mutants impairs SC process exten-
sion, and decreased signaling in Gpr56 mutants delays radial 
sorting theoretically through impaired SC adhesion to axonal 
membranes. In accordance with this hypothesis, a previous 
study demonstrated that inhibition of ROCK in vitro results 
in aberrant actin fiber organization and reduced SC adhesion 
because of loss of stress fibers (Melendez-Vasquez et al., 2004). 
ROCK is a serine–threonine kinase that regulates actin orga-
nization through phosphorylation of proteins that modulate 
Figure 7. Gpr56 mutants display neuropathy-like symptoms. (A and B) IHC on teased nerve fibers from WT (n = 3) and Gpr56−/− (n = 4) mouse SNs on 
P21 stained for Pan-NaV to mark nodes of Ranvier (arrowheads). Bar, 50 µm. (C) Quantification of internode length on P21 (P < 0.05, one-way ANO VA). (D 
and E) Hindlimb clasping observed in Gpr56 mutants (n = 8/11) but not WT siblings on P180 (n = 1/11). (F and G) Quantification of time on rotarod to assess 
sensorimotor control on P180 (genotype effect: ***, P < 0.001, two-way ANO VA; n = 11 WT, n = 16 Gpr56+/−, n = 13 Gpr56−/−) and P300 (genotype effect, 
*, P < 0.02, two-way ANO VA; n = 10 WT, n = 15 Gpr56+/−, n = 12 Gpr56−/−). Error bars represent SEM. (H) Quantification of EMG latency (m/s) in animals 
aged P200–P300 (***, P < 0.001, one-way ANO VA). Error bars represent SD. (I) Quantification of EMG response velocity (m/s) in animals aged P200–P300 
(***, P < 0.001, one-way ANO VA). Error bars represent SD. (J) Representative traces from EMG recordings from WT (black, n = 5), Gpr56+/− (blue, n = 12), and 
Gpr56−/− (red, n = 11) SNs. Arrows denote the point of the first positive deflection.
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Figure 8. Plectin and GPR56 physically and genetically interact in peripheral nerve. (A) GTP-RhoA assay to assess Gpr56 signaling in response 
to exogenous ligands. Addition of collagen III, a known activating ligand of Gpr56, to HEK 293T cells coexpressing Gpr56 result in elevation of GTP-RhoA 
levels over control (untransfected). Addition of prion protein (FT) does not induce Gpr56 signaling through RhoA. (B) Gpr56 Presto-Tango luciferase assay 
to assess Gpr56 signaling in HTLA cells. Addition of collagen III results in a significant elevation of luciferase compared with AcOH alone control (*, P < 0.05, 
unpaired Student’s t test). Addition of FT did not result in a significant elevation of luciferase relative to PBS controls (P = 0.0647, unpaired Student’s t test). 
(C) cAMP ELI SA assay to assess cAMP signaling through Gpr56 and Gpr126 (positive control) after addition of FT. Addition of FT to HEK 293T cells expressing 
Gpr126 results in a significant elevation of cAMP (**, P < 0.01, unpaired Student’s t test) compared with PBS controls. Addition of FT to cells expressing 
Gpr56 does not induce cAMP signaling (P = 0.4575, unpaired Student’s t test). (A–C) Data are representative of three biologically independent experiments. 
Error bars represent SEM. (D) Co-IP to assess interactions between GPR56 and plectin in P5 WT SNs (n = 8 nerves from four animals per replicate; n = 3 
replicates). Lane 1: plectin coimmunoprecipitates with GPR56 when the NTF of GPR56 fused to human IgG Fc (NTF-hFc) is used as a bait but not when 
pulling down with hFc alone (lane 2). (E) Analysis of plectin levels in P6 SNs. Plectin is significantly increased in Gpr56−/− nerves over sibling controls (**, P < 
0.002, unpaired Student’s t test, n = 12 nerves from six animals; error bars represent SEM). (F) Graphic model: Gpr56 promotes function of developing and 
mature SCs. During early SC development, Gpr56 signals through Gα12/13 and RhoA to modulate the actin cytoskeleton for efficient radial sorting of axons. 
During SC maturation/homeostasis, Gpr56 functions upstream of SRE BP1 to regulate myelin thickness and Remak SC biology, potentially through SRE 
signaling downstream of RhoA (gray dashed arrow). Concordantly, Gpr56 regulates mature myelin domain organization and myelin maintenance through 
direct interactions with the cytolinker protein plectin, which has been shown to physically interact with additional regulators of myelin domain organization 
(utrophin and β-dystroglycan). We therefore hypothesize that plectin serves as a docking center for cell signaling molecules that govern the partitioning of 
myelin into mature subdomains (Cajal bands and appositions) and helps generate these structures through its interactions with the cytoskeleton.
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cytoskeletal dynamics (Amano et al., 1996). Myosin II light 
chain is a direct target of ROCK, functions to stabilize and 
increase the contractility of actin-myosin filaments (Tan et 
al., 1992), and is required for ROCK-dependent reorganiza-
tion of actin fibers in SCs (Melendez-Vasquez et al., 2004). 
RNA-seq of Gpr56 mutant nerves during radial sorting (P3) 
revealed a significant dysregulation of genes that modify the 
actin and actomyosin cytoskeleton, including Myosin light 
chain 1 (Myl1, also known as Mhc1/Mhc3), Myosin Light 
Chain, Phosphorylatable, Fast Skeletal Muscle (Mylpf, also 
known as Mlc2b), and Mybpc1, a myosin binding protein. 
These findings support the hypothesis that GPR56 signals 
through RhoA and ROCK to modify the actin and actomy-
osin cytoskeleton to establish firm SC-axon contacts during 
radial sorting (Fig. 8 F, working model).
Gpr56 regulates peripheral myelin 
structure and maintenance
Although radial sorting recovers in Gpr56 mutants with time, 
we show that loss of GPR56 leads to multiple defects in ma-
ture SCs. First, we observed a significant increase in myelin 
thickness despite the delay in myelination onset. RNA-seq 
analysis of mutant nerves on P21 (postradial sorting defects) 
revealed a significant decrease in the expression of a cluster 
of SRE BP1 target genes. SRE BP1 is a transcription factor 
that regulates membrane lipid composition, and deletion of 
the primary isoform of SRE BP1 (Srebp1c) results in hyper-
myelination, incomplete separation of axons by Remak SCs, 
and neuropathy-like symptoms with age (Cermenati et al., 
2015). Although the signaling pathways upstream of SRE BP1 
activity are poorly defined, analysis of the promoter region 
of human and mouse SRE BP1 revealed SRE binding sites 
(Eberlé et al., 2004). GPR56-dependent RhoA signaling is 
known to function upstream of SRE to regulate neural pre-
cursor migration (Iguchi et al., 2008), suggesting that GPR56 
may also signal through this cascade to regulate SRE BP1 ex-
pression and in turn, myelin thickness and Remak SC dy-
namics (Fig. 8 F, working model).
In addition to changes in myelin thickness and Remak 
SC biology, we also observed a striking defect in mature my-
elin domain organization in Gpr56 mutants—a significant re-
duction in Cajal band number. Mature myelin is longitudinally 
organized into two primary structural domains: Cajal bands 
and appositions. Cajal bands are cytoplasmic channels sepa-
rated from one another by regions of completely compact SC 
membrane called appositions. The molecular mechanisms that 
drive Cajal band development are poorly understood, in part 
because few proteins have been linked to Cajal band develop-
ment. Mutations in the large intracellular cytolinker protein 
PLE CTIN in humans are linked to peripheral nerve defects 
(Winter and Wiche, 2013), and a recent study in mice de-
fined plectin as a key regulator of myelin domain organization 
(Walko et al., 2013). In SCs, plectin is specifically localized to 
Cajal bands where it interacts with β-dystroglycan and utro-
phin to restructure vimentin intermediate filaments in the cy-
toskeleton (Walko et al., 2013). Interestingly, β-dystroglycan is 
also a member of the Periaxin–DRP2–dystroglycan complex 
that stabilizes appositions for proper formation of Cajal bands 
(Sherman and Brophy, 2005). Here, we define plectin as a novel 
interacting protein of GPR56: GPR56 and plectin physically 
interact, and loss of Gpr56 results in up-regulation of plectin, 
as expected if plectin mediates GPR56 downstream signaling.
Plectin has now been shown to interact with proteins 
that are specifically enriched in Cajal bands (utrophin and 
GPR56) as well β-dystroglycan, which is present in both 
Cajal bands and in appositions as part of the Periaxin–DRP2–
dystroglycan complex. Furthermore, plectin is known to 
function as a scaffold for receptors that mediate intracellular 
signaling (Castañón et al., 2013). Together, these data suggest 
that that in myelinating SCs, plectin could serve as a docking 
center for both structural (Periaxin, DRP2, and utrophin) and 
signaling (GPR56 and β-dystroglycan) molecules required 
for efficient compartmentalization and long-term integrity 
of the myelin sheath (Fig. 8 F, working model). Although the 
downstream signaling pathways that promote peripheral my-
elin organization remain elusive, our RNA-seq analysis on 
P21 (when changes in Cajal bands are present in Gpr56 mu-
tant nerves) revealed significant dysregulation of genes that 
regulate microtubule dynamics. Disorganization of the mi-
crotubule cytoskeleton is present in Periaxin mutants, which 
also present with Cajal band defects (Court et al., 2004), sup-
porting the hypothesis that reorganization of microtubules is 
required for mature myelin domain assembly.
Neuropathy-like symptoms in GPR56 
mutants: links to human health
Several of the developmental defects observed in Gpr56 mu-
tants (e.g., hypermyelination and reduced Cajal bands) are 
known to precede disruptions in myelin integrity (Court 
et al., 2004, 2009; Sherman et al., 2012; Walko et al., 2013; 
Cermenati et al., 2015), and indeed, myelin maintenance 
is also defective in Gpr56 mutants relative to controls. We 
demonstrate that in Gpr56−/− mouse adults, impaired my-
elin stability coupled with shortened internode length results 
in behavioral deficits consistent with the recorded EMG la-
tency delay in Gpr56 mutants. Similar phenotypes are often 
noted in mouse models of peripheral neuropathy and in 
human neuropathy patients (Martini, 1999), suggesting that 
mutations in GPR56 could cause neuropathy-like symptoms 
in humans. Mutations in GPR56 cause several neurological 
disorders affecting the CNS, including bilateral perisylvian 
polymicrogyria (BPP or BPPR; OMIM #615752). BPP is a 
cortical brain malformation resulting in severe neurological 
impairments, including epilepsy and oromotor apraxia, and 
a minority of BPP patients also present with arthrogryposis 
multiplex congenital and exhibit EMG signatures consistent 
with PNS pathology (Poduri et al., 2010). Our work defines 
GPR56 as a novel, evolutionarily conserved regulator of SC 
development and myelin maintenance and suggests a mecha-
nism underlying PNS defects observed in BPP patients.
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MATERIALS AND METHODS
Zebrafish
Stocks and rearing conditions. Zebrafish (Danio rerio) were 
maintained in the Washington University Zebrafish Consor-
tium facility. All experiments were performed in compliance 
with Washington University's institutional animal care and 
use committee. Embryos were collected from pairwise mat-
ings and reared at 28.5°C in egg water (5  mM NaCl, 
0.17 mM KCl, 0.33 mM CaCl2, and 0.33 mM MgSO4). Em-
bryos and larvae were staged in days postfertilization (dpf) by 
using morphological markers (Kimmel et al., 1995). The 
gpr56stl13/stl13 line was genotyped as described previously 
(Ackerman et al., 2015).
3MO and synthetic mRNA injection. 3MOs targeting gna12, 
gna13a, and gna13b (3MO) are previously published (Lin et 
al., 2009; Ackerman et al., 2015) and were provided by F. Lin 
(University of Iowa, Iowa City, IA). 3MOs were combined 
and diluted in sterile water supplemented 1:10 with phenol 
red dye and then injected at a final concentration of 0.5 ng 
each in a total volume of 1 nl or 1 ng each in a total volume 
of 2 nl. To control for adverse side effects from the injection 
process, we also injected control siblings with an equal vol-
ume of phenol red diluted 1:10 in water (phenol red–injected 
controls). Constitutively active Rho (rhov14) was provided by 
L. Solnica-Krezel (Washington University, St. Louis, MO) and 
was transcribed and injected as described previously (Lin et 
al., 2009; Ackerman et al., 2015).
TEM. For zebrafish larvae, TEM was performed as described 
(Czopka and Lyons, 2011) by using a PEL CO BioWave Pro 
with SteadyTempTM Digital Plus water-recirculating system. 
Microwave-assisted fixation was used for all steps before Epon 
treatment. In brief, embryos were fixed in modified Kar-
novsky’s fix (4% paraformaldehyde, 2% glutaraldehyde, and 
0.1 M sodium cacodylate, pH 7.4) and left overnight at 4°C. 
After fixation, embryos were postfixed in 2% osmium tetrox-
ide in 0.1M sodium cacodylate and 0.1M imidazole, pH 7.4, 
washed, and treated with saturated uranyl acetate. Embryos 
were then dehydrated by using increasing concentrations of 
ethanol followed by 100% acetone and then infiltrated over-
night in an acetone-Epon mixture. Embryos were then trans-
ferred to 100% Epon, embedded in molds, and baked for at 
least 48 h at 65°C. Fish were examined at approximately the 
same body segment level to control for variability along the 
anterior/posterior axis. For preparation of pLLns from 
6-mo-old adult fish, we anesthetized animals in an ice-water 
bath and severed the hindbrain before dissecting a portion of 
the anterior pLLn, and fixation of adult tissue occurred as 
described previously (Monk et al., 2009). In brief, adult tissues 
were fixed via microwave-assisted fixation in modified Kar-
novsky’s fix as earlier in this paragraph and then postfixed in 
2% osmium tetroxide in 0.1M sodium cacodylate, washed, 
and dehydrated in increasing concentrations of ethanol fol-
lowed by 100% propylene oxide. The tissues were then sub-
merged in a 2:1 mixture of propolyene oxide/EPON for 1 h, 
followed by a 1:1 mixture overnight. The next day, the tissues 
were transferred to 100% Epon before embedding and baking 
at 65°C. Thin sections (70 nm) for all samples were mounted 
on mesh grids and stained with 8% uranyl acetate followed by 
Sato’s lead stain. We viewed sections on a Jeol (JEM-1400) 
electron microscope, and images were acquired with an AMT 
V601 digital camera. All images were processed and analyzed 
by using ImageJ and Adobe Photoshop software. At 3 dpf, 
quantifications were performed on the entire nerve. For 
rhov14 transient overexpression experiments, we examined 
five nerves from three WT, five nerves from three gpr56stl13/+, 
and seven nerves from four gpr56stl13/stl13 larvae for phenol red 
controls; and six nerves from three WT, six nerves from three 
gpr56stl13/+, and five nerves from three gpr56stl13/stl13 larvae in-
jected with 10 pg rhov14 synthetic mRNA. For 3MO exper-
iments, we examined 10 nerves from 6 WT, 10 nerves from 6 
gpr56stl13/+, and 9 nerves from 6 gpr56stl13/stl13 larvae for phe-
nol red control treatment. For larvae treated with 0.5 ng 
3MO, we examined 10 nerves from 6 WT, 8 nerves from 5 
gpr56stl13/+, and 7 nerves from 5 gpr56stl13/stl13 animals. For lar-
vae treated with 1 ng 3MO, we examined six nerves from 
three WT, five nerves from three gpr56stl13/+, and six nerves 
from n = 3 gpr56stl13/stl13 animals. For larval studies at 5 dpf, we 
examined seven nerves from four WT and six nerves from 
three gpr56stl13/stl13 animals. For adult studies, three nerves 
from three individuals at 6 mo of age for WT and gpr56stl13/+, 
and four nerves from three gpr56stl13/stl13 animals were analyzed.
Mice
Lines and rearing conditions. All mouse (Mus musculus) ex-
periments were performed in compliance with Washington 
University's Institutional Animal Care and Use Committee as 
well as the Animal Care and Use Committee at Boston Chil-
dren’s Hospital. The Gpr56 knockout mice were obtained 
pure on C57BL/6 (n = 11 generations) from the Mutant 
Mouse Regional Resource Centers (032342-UCD), main-
tained on a C57BL/6 background, and genotyped as de-
scribed previously (Li et al., 2008).
SC cultures and preparation of neuronal membranes. Pri-
mary rat SCs were prepared from SN on P3 as described 
(Feltri et al., 1992). SCs were maintained in SC medium: 
DMEM (Gibco), 1% FCS, 2 mM l-glutamine, 2 µM Forsko-
lin (Calbiochem), and 2 ng/ml recombinant human NRG1-β 
1 (R&D) and passaged not more than three times.
Neuronal membranes were prepared from dorsal root 
ganglia (DRG) of rat embryos at 15 gestational days. In brief, 
20 DRGs were plated on 9.5-cm2 dishes in C media: MEM 
(Gibco), 10% FBS, 4 g l-1 d-glucose, 2 mM l-glutamine, 25 
ng/ml BDNF (PeproTech), and 10 ng/ml NT-3 (PeproTech). 
After 12  h, cells were switched for 2 wk in NB medium 
(Gibco), 1X B27 supplement (Gibco), 4 g/l d-glucose, 2 mM 
l-glutamine, 25 ng/ml BDNF (PeproTech), and 10 ng/ml 
NT-3 (PeproTech). To obtain neuron-only cultures, the cells 
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were treated with FUDR (10  µM floxuridine and 10  µM 
uridine) in NB medium for three cycles (2 d with FUDR, 
2 d without FUDR). Neurons were collected by scraping 
the network with forceps and homogenized in PBS with a 
Dounce homogenizer. The homogenized solution was cen-
trifuged at 300 g for 20 min to remove debris and collagen. 
The supernatant was centrifuged at 30,000  g for 1  h. The 
pellets were resuspended in DMEM (67 µl for each 9.5-cm2 
dish) and stored at −80°C for 1 mo. To test their activity, 
membranes were centrifuged onto serum-starved, rat primary 
SCs, incubated at 37°C for an additional 20 min, lysed, and 
analyzed by Western blotting for Akt activation.
Pseudopod assay. Pseudopod assay was performed as de-
scribed previously (Poitelon et al., 2015). In brief, starved SCs 
were plated onto the upper compartment of the Boyden 
chamber insert (3414; Corning). Cells were maintained in 
DMEM, 2 mM l-glutamine and 0.5% BSA for 4 h at 37°C. 
Then pseudopods were allowed to grow for 2 h at 37°C by 
replacing bottom-chamber DMEM with neuronal mem-
brane suspension. After induction, inserts were washed twice 
in PBS, fixed with ice-cold methanol for 30 min on ice, and 
washed again in PBS. For each filter, either the cell bodies on 
the upper surface or the pseudopods on the undersurface 
were removed with a cotton swab.
Sample preparation for shotgun proteomics for SC pseudo-
pod assay. Microporous filters with either pseudopods or cell 
bodies were manually cut into tiny pieces and suspended in 
200 µl of cold lysis buffer (50 mM Tris-FA, 150 mM NaCl, 
0.5% sodium deoxycholate, 2% SDS, 2% IGE PAL CA-630 
[Sigma-Aldrich], pH 8.0) supplemented with protease/phos-
phatase inhibitor cocktail tablets (Roche Applied Science). 
The samples were sonicated until the liquid turned clear and 
were then placed on ice for 30 min, followed by a 30-min 
centrifugation at 20,000 g under 4°C. Supernatant from all 
samples was carefully transferred to Eppendorf tubes, and pro-
tein concentrations were measured by bicinchoninic acid 
assay kit (Pierce Biotechnology, Inc.).
For each extraction, 100 µg of protein was subjected to a 
surfactant-aided precipitation/on-pellet digestion procedure 
(An et al., 2015) to generate tryptic peptides for LC-MS anal-
ysis. Proteins first undergo reduction and alkylation by 3 mM 
tris(2-carboxyl)phosphine and 20 mM iodoacetamide. Both 
steps were performed under 37°C for 30 min in darkness, 
with constant oscillation in an Eppendorf Thermomixer (Ep-
pendorf). Proteins were then precipitated by addition of eight 
volumes of chilled acetone, and the samples were incubated 
under −20°C overnight. Precipitated proteins were collected 
by centrifugation at 20,000  g under 4°C for 30 min, and 
the supernatant portion was removed. This step allowed the 
elimination of detergents and unwanted contaminants (e.g., 
phospholipids), which will compromise the analytical quality 
of the LC-MS system. Protein pellets were rinsed with 500 µl 
of chilled acetone/water mixture (85:15, vol/vol percentage), 
air-dried for 5 min, and resuspended in 80 µl Tris-FA. Trypsin 
from porcine pancreas (Sigma-Aldrich) at a concentration of 
0.25 µg/μl was added to the samples in two steps, at a final 
enzyme/substrate ratio of 1:20 (wt/wt percentage). The sam-
ples were incubated under 37°C overnight (18–20 h) with 
constant oscillation to achieve complete proteolytic cleavage. 
The digestion step was terminated by addition of 1 µl formic 
acid, after which the samples were centrifuged at 20,000 g 
under 4°C for 30 min and transferred to LC vials.
Long-gradient nano reversed-phase LC-MS for SC pseudo-
pod assay. The nano RPLC system used in the present study 
consists of a Spark Endurance autosampler (Emmen) and an 
ultrahigh-pressure Eksigent Nano-2D Ultra capillary/nano 
LC system. A nano LC/nanospray setup featuring 
low-void-volume and high-chromatographic reproducibility 
was used so that comprehensive separation of complex pep-
tide samples could be achieved. Mobile phase A was 0.1% 
formic acid in 2% acetonitrile, whereas mobile phase B was 
0.1% formic acid in 88% acetonitrile. Peptides were first 
loaded onto a large inner-diameter trap (300 µm inner diam-
eter × 1 cm, packed with Zorbax 3M C18 material) with 1% 
B at 10 µl min−1, and the trap was washed for 3 min before 
bringing in line with the nano LC flow path. A series of op-
timized gradients (250 nl/min) was used to back-flush the 
trapped peptides onto the nano LC column (75 µm inner 
diameter × 100 cm, packed with Pepmap 3M C18 material), 
which was heated homogenously to 52°C to improve chro-
matographic resolution and reproducibility. The 7-h gradient 
profile used for extensive peptide separation was listed as fol-
lows: 3–8% B over 15 min, 8–24% B over 215 min, 24–38% 
B over 115 min, 38–63% B over 55 min, 63–97% B in 5 min, 
and finally isocratic at 97% B for 15 min.
An LTQ Oribtrap XL mass spectrometer (Thermo 
Fisher Scientific) was used for peptide detection. Repro-
ducibility of ionization efficiency was maintained via rins-
ing and conditioning of the nanospray needle (by dripping 
50% methanol after every three runs). The instrument was 
carefully calibrated for mass accuracy and Fourier transform 
transmission. One complete scan cycle consisted of one MS1 
survey scan (m/z 310−2,000) at a resolution of 60,000 and 
seven subsequent MS2 scans by collision-induced dissociation 
activation mode to fragment the top seven most-abundant 
precursors in the survey scan. The automatic gain control tar-
get was set to 8 × 106, which allowed highly sensitive detec-
tion with little compromise to mass accuracy and resolution. 
Dynamic exclusion was enabled with the following settings: 
repeat count = 1, repeat duration = 30 s, exclusion list size = 
500, and exclusion duration = 40 s. The activation time was 
30 ms with an isolation width of 3 D for ion trap mass spec-
trometry; the normalized activation energy was 35%, and the 
activation q was 0.25. All 20 samples were randomly analyzed.
Protein identification and quantification for SC pseudopod 
assay. LC-MS.raw files were matched to a combined 
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Swiss-Prot Mus musculus and Rattus norvegicus protein da-
tabase because of the incomprehensiveness of the current rat 
protein database. Files were matched by SEQ UEST by using 
a target-decoy search strategy, in which a concatenated pro-
tein database with both forward and reverse sequences was 
used (Elias et al., 2005). The searching parameters include 15 
ppm for precursor ion mass, 1.0 D tolerance for fragment ion 
mass, 2 for maximal missed cleavages, carbamidomethylation 
of cysteine as fixed modification, and oxidation of methi-
onine as dynamic modification. Peptide inference, protein 
grouping, and false-discovery rate control was accomplished 
by Scaffold (v4.3.2; Proteome Software Inc.; Searle, 2010). 
Corresponding parameters include for minimal peptide 
length, 25 ppm for parent mass tolerance; 0.1 for DeltaCn; 
2.1, 2.2, 2.6, 3.5 (pseudopods); and 1.1, 1.4, 1.7, 2.5 (cell bod-
ies) for Xcorr thresholds for singly, doubly, triply, and 
quadruply charged ions.
Chromatographic alignment and global intensi-
ty-based MS1 feature detection/extraction were accom-
plished by SIE VE (v2.1.377; Lopez et al., 2011). The major 
steps we took are as follows. (a) Alignment of LC-MS 
runs via the use of ChromAlign algorithm. The qual-
ity of LC-MS runs was monitored and benchmarked by 
the alignment scores and base-peak ion current intensity 
among all runs. (b) Determination of quantitative “frames” 
based on m/z and retention time in the aligned collec-
tive dataset. The reliability of quantification was assured by 
retaining only frames with high-quality area-under-the-
curve data (e.g., signal/noise ratio >10). (c) Calculation 
of peptide ion intensities for each frame. The resulting 
.sdb files were incorporated with spectrum reports ex-
ported from Scaffold to associated MS2 fragmentation 
scans with each frame by using customized R scripts. An-
other in-house-developed R package was used for the 
normalization of ion current intensities for each protein 
(by quantile ion intensities among individual runs) and the 
aggregation of sun intensities from frame levels to protein 
levels. The calculation of protein-abundance ratio, as well 
as the evaluation of statistical significance with Student’s 
t test (unpaired) between induced and noninduced (i.e., 
control) groups, was conducted to determine proteins with 
significant changes in abundance. Detailed information 
about the quantitative proteomics workflow is described 
in several pieces of our previous works (Tu et al., 2014a,b; 
An et al., 2015; Shen et al., 2015).
Bioinformatics for SC pseudopod assay. The pathway and sig-
naling networks were analyzed by using Ingenuity Pathways 
Analysis software (Ingenuity Systems). Lists of proteins with 
relative enrichment in pseudopods by neuronal membrane 
were associated with canonical pathways in Ingenuity Path-
ways Analysis. The probability of association between the 
dataset and the canonical pathway proteins was measured by 
using Fisher’s exact test (Dataset 1). Networks of proteins 
were algorithmically generated based on their connectivity.
RT-PCR. Standard RT-PCR was performed on cDNAs derived 
from purified mouse DRG and purified rat SCs (gifts from Y. 
Sasaki, J. Milbrandt laboratory, Washington University, St. Louis, 
MO). For mouse Gpr56, the following primer pair was used to 
amplify a 577-bp fragment that spans exons 5–10: 5′-CAG 
 TTA CAG AGC CTG GAG TC-3′ and 5′-TGT GAG TGG CTT 
 CTA CCT CT-3′. For rat Gpr56, the following primer pair was 
used to amplify a 573-bp fragment that spans exons 9–12: 
5′-GAG GGC TGT GAG ACT GTT AG-3′ and 5′-TAG AGG 
 GGT AGA TGA CAT GG-3′. The following primers were used 
to amplify a 702-bp fragment from exons 3–6 of mouse and 
exons 2–6 of rat Gapdh: 5′-GCC ATC AAC GAC CCC TTC 
 ATT-3′ and 5′-CGC CTG CTT CAC CAC CTT CTT-3′.
TEM. For standard EM analyses, tissues were drop-fixed in 
modified Karnovsky’s fix and processed as described previ-
ously (Monk et al., 2011). Semithin sections (200 nm) were 
stained with toluidine blue and imaged with an AxioCam 
MRm on a light microscope (Zeiss AxioImager M2). Thin 
sections (70 nm) were treated as described for zebrafish anal-
yses. For examination of dorsal and ventral roots, two roots 
each were analyzed from two WT and three Gpr56−/− ani-
mals on P180. The number of animals examined at time point 
for SN analyses is as follows: P3, six independent regions 
(4,000×) of nerve from three WT, three Gpr56+/−, and four 
Gpr56−/−; P14, four independent regions (2,000×) of nerve 
from three WT, three Gpr56+/−, and three Gpr56−/−; P21, four 
independent regions (2,000×) of nerve from three WT and 
three Gpr56−/−; P90, three independent regions (2,000×) of 
nerve from three WT, three Gpr56+/−, and four Gpr56−/−; 
P180, three independent regions (2,000×) of nerve from 
three WT, three Gpr56+/−, and three Gpr56−/−; and P300, 
three independent regions (2,000×) of nerve from three WT, 
three Gpr56+/−, and three Gpr56−/−.
For all experiments, myelinated fibers showing my-
elin outfoldings, infoldings, or demyelinating profiles 
were considered abnormal.
Antibodies for IHC. We used the following primary antibod-
ies: mouse anti–Gpr56-H11 (1:1,000; Jeong et al., 2012), rab-
bit anti–Ki67 (1:400; Abcam; Mogha et al., 2013), rabbit 
anti–TUJ1 (1:1,000; Covance; Mogha et al., 2013), rat anti–
MBP (1:10; AbD Serotec; Mogha et al., 2013), and mouse 
anti–pan sodium channel (IgG1, 1:400; Sigma-Aldrich; Saito 
et al., 2003). Fluorescently conjugated secondary antibodies 
were applied at a concentration of 1:1,000 (Invitrogen). 
Rhodamine-phalloidin (1:100; Invitrogen; Terada et al., 2012) 
was used for staining of Schmidt-Lanterman incisures.
IHC. For tissue sections, nerves were harvested and drop-fixed 
in 4% paraformaldehyde overnight, transferred into 30% su-
crose, and then embedded in optimal cutting temperature 
compound. IHC was done as described previously on 
7–10-µm-thick sections (Jeong et al., 2012). Stained sections 
were imaged with an AxioCam MRm on a light microscope 
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(Zeiss AxioImager M2), and analyses were performed in Im-
ageJ software. SNs and DRG from three WT were used for 
expression analyses. SNs from three WT and two Gpr56+/− 
mice (controls) and three Gpr56−/− mice were used for quan-
tification of cell proliferation on P3. For teased nerve 
preparations, nerves were harvested and fixed for 30 min in 
4% paraformaldehyde before teasing on glass slides. Samples 
were then permeabilized for 15 min in acetone at −20°C 
before antibody staining.
RNA sequencing. Mouse SNs were harvested on P3 and P21 
(n = 4 WT and n = 4 Gpr56−/− on P3; n = 3 WT and n = 3 
Gpr56−/− on P21), flash frozen in liquid nitrogen, and stored 
at −80°C. Total RNA was extracted by using an RNeasy 
Mini kit (74104; Qiagen). First, nerves were allowed to thaw 
on ice for at least 5 min in Buffer RLT containing 
β-mercaptoethanol. During this time, small spring-loaded 
surgical scissors were used to cut the nerves into smaller 
pieces while the nerves were still in the liquid. Scissors were 
cleaned with 100% ethanol between each sample. Once 
thawed, nerves were homogenized by using a TissueRuptor 
for ∼30–60 s followed by vortexing briefly, then passing the 
sample through a syringe and successively smaller needles (22 
gauge and then 28 gauge) at least 10 times each or until large 
clumps of tissue were no longer visible. We then followed 
manufacturer instructions for the RNeasy Mini kit to obtain 
total RNA for each animal. RNA was eluted in 30 μl elution 
buffer and then submitted on dry ice to the Genome Tech-
nology Access Center at Washington University in St. Louis, 
MO, for processing and RNA-seq. Libraries were generated 
by using Clontech Library Prep kits, and 12 samples were run 
on a single lane of Illumina 3000, 1 × 50 bp. Approximately 
20–40 million mapped reads were generated per sample. All 
reads were mapped with STAR (Dobin et al., 2013).
R/Bioconductor was used for subsequent analysis. 
Differential expression analysis was performed by using the 
packages, DESeq (Anders and Huber, 2010), and edgeR 
(Robinson et al., 2010) in R (http ://www .R -project .org). 
The original p-values were corrected via false-discovery rate 
for multiple testing errors. In addition to a false-discovery 
rate of <0.05, we considered genes differentially expressed 
if the adjusted p-value was <0.05 and fold change >1.4× 
(log2[fold change] >0.5). Individual P3 and P21 volcano plots 
and comparison between the two developmental stages were 
generated on normalized gene expression by using R. GO 
analysis was performed with MetaCore and g:Profiler.
Morphometry. G-ratios were calculated from a total of ∼180 
myelinated fibers per genotype (∼60 fibers each from three 
mice per genotype) by taking the ratio of axon diameter to 
fiber diameter. Measurements were obtained by using ImageJ 
software. Internodal lengths were similarly measured from 
IHC images in ImageJ software. For internode analyses, a total 
of a total of 21 WT and 64 Gpr56−/− fibers were measured 
per genotype on P21 (n = 3 mice per genotype). For apposi-
tion quantifications from electron micrographs, a total of 154 
WT and 168 Gpr56−/− myelinated fibers were analyzed on 
P21 (n = 3 mice per genotype). For analysis of 
Schmidt-Lanterman incisures on P300, a total of 104 WT fi-
bers and 93 Gpr56−/− fibers were analyzed (n 
= 3 mice per genotype).
Serial scanning EM and reconstruction. Nerves from P90 
mice (three nerves from three WT and three Gpr56−/− ani-
mals) were harvested and drop-fixed in modified Karnovsky’s 
fixative overnight. Nerves were then washed into 0.1 M so-
dium cacodylate before staining, embedding, and imaging at 
Renovo Neural Inc. Approximately 400 serial sections were 
imaged (100 nm each in thickness) per nerve, and data were 
analyzed and reconstructed by using IMOD software (Kremer 
et al., 1996). Videos depicting data and models from serial EM 
analyses (Videos 1, 2, 3, and 4) were generated in ImageJ software.
Motor function. Motor function tests were performed in the 
Animal Behavior Core Lab at Washington University School 
of Medicine. The accelerated rotarod was used to assess senso-
rimotor function and grip strength and was performed on a 
cohort of 11 WT, 16 Gpr56+/−, and 13 Gpr56−/− mice on 
P180, and the same cohort was used for testing on P300 (n = 
10 WT, n = 15 Gpr56+/−, and n = 12 Gpr56−/−) as described 
previously (Idol et al., 2014).
Electrophysiology. Animals (WT, n = 5; Gpr56+/−, n = 12; 
Gpr56−/−, n = 11) were anesthetized by using 4% isoflu-
rane/96% oxygen (induction) and 2% isoflurane/98% oxygen 
(maintenance) administered by inhalation. After preparation 
of the sterile field, the right SN was isolated from the sciatic 
notch to below the point of trifurcation, distal to the popliteal 
artery. Cathodic, monophasic electrical impulses (duration = 
50 μs, frequency = single, amplitude = 1 mA) were generated 
by a single-channel isolated pulse stimulator (model 2100; 
A-M Systems Inc.) and delivered to the SN proximal to the 
implanted device via bipolar platinum/iridium microwire 
electrodes (Medwire). Resulting EMGs were then differen-
tially recorded in the tibialis anterior muscle by using intra-
muscular microwire electrodes (4 mil; California Fine Wire). 
Measured signals were band-pass filtered (low pass = 1 Hz, 
high pass = 5 kHz, notch = 60 Hz) and amplified (gain = 
1,000–10,000×) by using a two-channel microelectrode AC 
amplifier (model 1800; A-M Systems, Inc.) before being re-
corded on a desktop PC (Dell Computer Corp.) equipped 
with a data acquisition board (DT3003/PGL; Data Transla-
tions). EMG traces were digitally recorded while peak latency 
and maximal amplitude were calculated by using custom 
Matlab software (The MathWorks, Inc.).
Western blot and GTP-Rho pull-down assay. For analysis of 
RhoA activity in mouse nerves, P6 litters consisting of 
Gpr56+/+, Gpr56+/−, and Gpr56−/− mice were used in 
each of three separate experiments (we combined four 
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nerves from the same genotype for one pull-down and did 
three separate experiments, with a total of 12 for each gen-
otype group). P6 SNs were dissected under a Leica stereo 
microscope (MZ 6; Leica Pte Ltd.); four nerves from same 
the genotype were combined in one group, powdered on 
liquid nitrogen, then lysed in ice-cold RIPA buffer (1% 
Nonidet P-40, 50  mM Tris, pH 7.6, 120  mM NaCl, and 
1 mM EDTA) containing protease inhibitor cocktail set 1 
(Calbiochem). The lysates were cleared of insoluble materi-
als by centrifugation at 16,000  g for 10 min at 4°C. The 
protein concentration was determined by a Bio-Rad pro-
tein assay method (Bio-Rad) according to the manufactur-
er's protocol, and equal amounts of protein were used for 
each pull-down assay. The GTP-Rho pull-down assay was 
performed as previously described (Luo et al., 2011). In 
short, tissues were pulverized on liquid nitrogen, lysed in 
300 µl of ice-cold RIPA buffer containing protease inhibi-
tors with a cell disruptor for 10 min and homogenized with 
a 26-gauge syringe needle. Equal amounts of total protein 
were incubated with 60 µg GST-RBD beads (Cytoskeleton) 
at 4°C for 90 min. The beads were washed twice with lysis 
buffer and once with Tris-buffered saline buffer. Bound Rho 
proteins were eluted by Laemmli sample buffer and detected 
by Western blot by using mouse monoclonal anti–RhoA 
antibody (ARH04, 1:1000; Cytoskeleton). For analysis of 
GPR56-dependent RhoA signaling in vitro, HEK 293T 
cells were plated in 6-well plates (500,000 cells/well) and 
transfected with mouse Gpr56 (Luo et al., 2014) or not. 
24 h posttransfection, cells were subjected to serum starva-
tion for 36 h followed by treatment with human collagen III 
(84 nM, CC054, positive control; Sigma-Aldrich) or 
full-length recombinant FT (res. 23–110, 10 µM) and as a 
control with either 0.5 M acetic acid or PBS, respectively, 
for 5 min. Cells were lysed in lysis buffer (PBS + 1% Triton 
X-100 + 1× protease inhibitors) followed by pull-down of 
RhoA-GTP (Luo et al., 2011). We also blotted for GPR56 
(ab172361, concentration of 1 µg/ml; Abcam) to assess the 
success of transfection and actin (MAB1501, 200 ng/ml an-
tibody and c concentration; Chemicon) for a loading con-
trol. Data are representative of three biologically 
independent experiments.
Gpr56 PRE STO-Tango assay. HTLA cells (a HEK293 cell line 
stably expressing a tTA-dependent luciferase reporter and a 
β-arrestin2-TEV fusion gene) were provided by the labora-
tory of B. Roth (University of Noth Carolina, Chapel Hill, 
NC; Kroeze et al., 2015). Cells were plated in six-well plates 
(500,000 cells/well) and transfected with either Gpr56 Tango 
plasmid (Addgene) or as a control with pCDNA3 plasmid. 
24 h posttransfection, cells were subjected to serum starvation 
for further 24 h followed by treatment with human collagen 
III (150 nM; CC054; Sigma-Aldrich) or full-length recombi-
nant FT (res. 23–110, 10 µM), and as a control, with either 
0.5 M acetic acid or PBS, respectively, overnight. Cells were 
washed with PBS and processed with Bright-Glo luciferase 
system (E2610; Promega) according to manufacturer’s proto-
col. 200 µl of Bright-Glo solution, diluted in the assay buffer, 
was added to 25 µg of cell lysate, and followed by 20 min of 
incubation, luciferase activity was measured (as a function of 
chemiluminescence). Data are representative of three biolog-
ically independent experiments.
cAMP assay. cAMP assay was done with a colorimetric 
competitive immunoassay (Enzo Life Sciences) as de-
scribed previously (Küffer et al., 2016). In brief, HEK 
293T cells were transfected with either human GPR126 
(cloned into pCDNA3.1/V5-His-TOPO vector) or 
mouse Gpr56 (cloned into pCDNA3.1 vector) and 48 h 
posttransfection were treated with either PBS or full-length 
recombinant FT (10 µM) and then processed for quantifi-
cation of cAMP. Data are representative of three biologi-
cally independent experiments.
Co-IP and immunoblotting. Co-IP and immunoblotting were 
done as previously described (Luo et al., 2011). In brief, P5 
mouse SNs (n = 8 nerves from four animals for each co-IP) 
were lysed in RIPA buffer as described for the GTP-RhoA 
pull-down assay. After extraction at 4°C with rocking, insolu-
ble material was removed by centrifugation, and lysates were 
precleared for 1 h at 4°C with protein G-Sepharose (101241; 
Invitrogen). The lysate was equally divided into two; half of 
the lysate was used for GPR56 IP, and the other half was used 
for the control IP. Protein G beads were then used to 
pull-down the GPR56NTF-hFc protein complex. Immuno-
complexes were subjected to SDS-PAGE and Western blot by 
using pan-plectin antibody (MAB5674; Sigma-Aldrich), and 
rabbit anti–human IgG Fc antibody (31142; Thermo Fisher 
Scientific) following standard protocols.
Plectin expression assay. P6 mouse SNs (n = 12 nerves from 
six animals per genotype) were collected and lysed as de-
scribed for the GTP-RhoA pull-down assay. Plectin levels 
were assessed by Western blot by using a pan-plectin antibody 
(MAB5674; Sigma-Aldrich). Two nerves were pooled from 
each animal to make up a single replicate.
Statistical analyses
Analyses were performed blinded to genotype and treatment. 
All data are presented as the mean ± SEM unless otherwise 
noted. To represent significance, *, P < 0.05; **, P < 0.01; 
***, P < 0.001; ****, P < 0.0001. A minimum of two tech-
nical replicates was performed for each described experiment. 
Although we did not perform statistical tests to predetermine 
sample size, our samples sizes are similar to previously pub-
lished studies in the field. Statistical analyses were performed 
by using one-way ANO VA, two-way ANO VA, or unpaired 
Student’s t test with two tails with unequal variance when 
required conditions were met. A departmental statistician 
was consulted to confirm the appropriateness of each statis-
tical analysis performed.
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Online supplemental material
Fig. S1 shows IHC analysis of cellular proliferation and the 
total cell number in P3 mutant and control mouse SNs 
as well as an assessment of overall saphenous nerve size 
by toluidine blue staining, which can be affected by cell 
number. Fig. S2 shows TEM images assessing pLLn integrity 
and myelin ultrastructure in gpr56stl13/stl13 zebrafish mutants 
during development and in adulthood to show conservation 
with mouse phenotypes. Fig. S3 shows RNA-seq analysis of 
the transcriptome of Gpr56 mutant and WT control nerves 
on P3 and P21. Fig. S4 Shows further structural analysis 
of Gpr56 mutant nerves: Schmidt Lanterman incisure 
quantification by IHC, toluidine blue, and TEM images of 
Gpr56−/− dorsal and ventral roots compared to control roots 
on P180. Analysis of Gpr56 expression in neurons versus 
SCs is shown. Fig. S5 shows additional TEM reconstructions 
to supplement observations in Fig. 6. Video 1 shows serial 
reconstruction of a myelinated fiber from a WT mouse SN 
on P90 generated from 350 successive scanning EM images 
(100 nm thick). Video 2 shows serial scanning EM images 
(210 sections shown, 100 nm thick) from a WT mouse SN 
on P90. Video 3 shows serial reconstruction of a myelinated 
fiber from a Gpr56−/− mutant mouse SN on P90 generated 
from 350 successive scanning EM images (100 nm thick). 
Video  4 shows serial scanning EM images (210 sections 
shown, 100 nm thick) from a Gpr56−/− mutant mouse SN 
on P90. Dataset 1 is a summary of all proteins significantly 
upregulated in SC pseudopods after induction and analysis of 
the major cellular pathways found to be enriched. Dataset 2 
is a summary of gProfiler results for significantly enriched or 
depleted pathways in Gpr56 mutant nerves based on RNA-
seq analyses on P3 and P21. Raw data files can be accessed 
from Zenodo (https ://zenodo .org /record /1154250). 
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